As It Soaks Up Good Trial Results, Amarin Ponders Partners - Or None

A second set of clinical trial results expands the potential market for AMR101 tenfold, triggering increased investor and partnership interest.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet